EMA receives application for conditional marketing authorisation of Moderna (MRNA) COVID-19 vaccine

Go back to EMA receives application for conditional marketing authorisation of Moderna (MRNA) COVID-19 vaccine

Moderna (MRNA) Quickly Pares Gain, Still Up 4.3%

December 1, 2020 10:36 AM EST

Moderna (NASDAQ: MRNA) Quickly Pares Gain, Still Up 4.3%

... More